GleamWall
中文EN

LNTH Lantheus Holdings, Inc.

In Vitro & In Vivo Diagnostic Substances · Nasdaq · SEC CIK 1521036 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY2.4%
TTM net income YoY61.0%
TTM EPS YoY66.8%
Revenue 3-yr CAGR9.0%
Net income 3-yr CAGR37.4%

Margins

Gross margin61.3%
Operating margin18.6%
Net margin17.3%
FCF margin25.2%
EBITDA margin24.4%

Returns

ROE21.8%
ROA11.4%
ROIC (approx.)18.0%
Asset turnover0.66x

Leverage & solvency

Liabilities / assets44.8%
Debt / equity0.42x
Current ratio3.25x
Interest coverage14.70x

Cash quality & payout

Operating cash flow / net income1.52x
Accruals ratio-5.9%
Payout ratio—
Capex / revenue1.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$1.54B$1.53B
Cost of revenue$599.66M$545.62M
Gross profit$941.95M$988.29M
R&D expense$177.31M$168.10M
SG&A expense$275.12M$193.69M
Operating income$310.83M$456.98M
Interest expense$19.75M$19.67M
Pretax income$313.79M$430.98M
Income tax$80.23M$118.53M
Net income$233.56M$312.44M
EBITDA$380.93M$521.60M
EPS (basic)3.464.52
EPS (diluted)3.414.36
Weighted avg. shares (diluted)68.44M71.65M
Balance sheet
Cash & equivalents$359.12M$914.49M
Receivables$358.64M$321.26M
Inventory$64.67M$68.03M
Current assets$899.96M$1.33B
PP&E, net$163.69M$176.80M
Goodwill$239.52M$61.19M
Intangibles$722.78M$161.76M
Total assets$2.23B$1.98B
Current liabilities$333.42M$240.53M
Short-term debt$738,000$974,000
Long-term debt$568.68M$565.28M
Total debt$569.42M$566.25M
Total liabilities$1.14B$892.33M
Shareholders' equity$1.09B$1.09B
Net debt$210.29M-$348.23M
Shares outstanding64.59M68.45M
Cash flow statement
Operating cash flow$390.14M$544.75M
Capital expenditure$36.09M$51.62M
Free cash flow$354.05M$493.12M
Investing cash flow-$627.17M-$226.01M
Financing cash flow-$316.58M-$118.54M
Depreciation & amortization$70.10M$64.62M
Stock-based compensation$85.56M$76.39M
Share buybacks$300.02M$100.00M

Free plan shows the latest 2 periods; Pro shows all 13 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.